Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: John Carragher who wrote (325)	9/8/1998 7:16:00 PM
From: Bull-like	Read Replies (4) \| Respond to of 642

Anthony, thanks very much for the info.. Compared to other big-pharma, Lilly is still relatively cheap using this year/next year earning estimates. These estimates are all without and potential or planned new products on the market. Of course, JMHO. Da bull

To: John Carragher who wrote (325)	9/10/1998 8:19:00 AM
From: Anthony Wong	Respond to of 642

Gene Discovery Firm Affymetrix Signs Three-Year Pact With Eli Lilly September 09, 1998 2:45 PM SANTA CLARA, Calif. -(Dow Jones)- Affymetrix Inc. said Wednesday it signed a three-year pact granting Eli Lilly & Co. broad access to its line of tools used in genetic discovery. Affymetrix has developed a system called GeneChip, which is used to analyze and manage genetic information to improve diagnosis and treatment of disease. GeneChip packs thousands of DNA probes on a wafer and features instruments to process and interpret the genetic data. Affymetrix uses the system and related technology to facilitate the analysis of tissue samples. Terms of the pact, which is a volume discount pricing agreement designed for large research organizations, weren't disclosed. Affymetrix (AFFX) said Eli Lilly will monitor gene expression for use in its research and development activities. Other Affymetrix customers include American Home Products Corp, Roche Holding AG, Glaxo Wellcome PLC, Hoechst AG, Merck & Co., Novartis AG, Warner Lambert Co. and Pfizer Inc. Copyright (c) 1998 Dow Jones & Company, Inc. All Rights Reserved. smartmoney.com